This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Annabelle Fowler is a panelist on “Navigating Today’s Life Sciences M&A Landscape: Charting the Latest Trends and Challenges in Pharma and Biotech Dealmaking” and we discuss the current state of M&A activity in the biopharma space, as well as what projections for dealmaking activity will look like in the year ahead.
CRA is also a proud sponsor of the conference.
For more information on this event, click here.
Introduction and how the sampling industry works The landscape of market research sampling has had to evolve significantly in recent years. AI-driven bots are...
What would happen to the healthcare system without antibiotics? The responsible use of antibiotics requires minimizing their usage, which discourages...
